Investigation of a Novel PD-L1:NLRP3 Inflammasome Activation Pathway as a Driver of Metastatic Recurrence
Research Grant
Administered By
Medicine, Medical Oncology
Awarded By
Merck Sharp & Dohme
Start Date
December 18, 2019
End Date
July 1, 2024
Administered By
Medicine, Medical Oncology
Awarded By
Merck Sharp & Dohme
Start Date
December 18, 2019
End Date
July 1, 2024